Namely, radiation-induced immunogenic cell death (ICD) activates antigen-presenting cells, which facilitate the induction of Th1 and CTL specific to neoantigen and common cancer-rejection antigens such as WT1 and survivin. This evidence concerns the gene BIRC5 and cancer.